Evidence map›Paper›PMID 35517817›Full record

ArticleFrontiers in pharmacology2022

Lipophilic Constituents in

Ya-Xin Tang, Mingming Liu, Long Liu, Bo-Rui Zhen, Tian-Tian Wang, Na Li, Nanning Lv, Zhenyu Zhu, Guoquan Sun, Xiaobo Wang and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Ameliorative Effect of Herbal Medicine in the Management of Hepatotoxicity.Endocrine, metabolic & immune disorders drug targets · 2025
    Review
  2. Article
  3. Review
  4. The Bioactive Compounds ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Experimental and therapeutic medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Ya-Xin TangKey Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China.
Mingming LiuLianyungang Second People's Hospital, Lianyungang, China.
Long LiuGongQing Institute of Science and Technology, Gong Qing, China.
Bo-Rui ZhenSchool of Pharmacy, Second Military Medical University, Shanghai, China.
Tian-Tian WangSchool of Pharmacy, Second Military Medical University, Shanghai, China.
Na LiSchool of Medicine, Shanghai University, Shanghai, China.
Nanning LvLianyungang Second People's Hospital, Lianyungang, China.
Zhenyu ZhuSchool of Pharmacy, Second Military Medical University, Shanghai, China.
Guoquan SunXinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xiaobo WangKey Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China.
Si ChenSchool of Medicine, Shanghai University, Shanghai, China.
Second Military Medical University · CNShanghai University · CNShenyang Pharmaceutical University · CNXian Yang Central Hospital · CNXinHua Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver fibrosis is currently a global health challenge with no approved therapy, with the activation of hepatic stellate cells being a principal factor. Lipophilic constituents in

Indexed as

hepatic stellate cellsJAK1/STAT3 signaling pathwayliver fibrosisnetwork pharmacologySalvia miltiorrhiza

Identifiers

PMID35517817
PMCPMC9065469
OpenAlexW4224294013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.